You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EGFR alteration

Showing 1 - 25 of 2,836
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Cancer Trial (Savolitinib, Durvalumab)

Recruiting
  • Lung Cancer
  • Beijing, China
  • +2 more
Jan 11, 2023

Solid Tumor Trial in Korea, Republic of (ORIC-114)

Recruiting
  • Solid Tumor
  • Cheongju-si, Korea, Republic of
  • +7 more
Apr 12, 2022

Radiomics for prEdiction of lunG cAncer biologY

Active, not recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • PET/CT
  • Poitiers, France
    CHU Poitiers
Apr 5, 2023

Non Small Cell Lung Cancer, Advanced Solid Tumor Trial in France (EGFR gene mutation analysis on liquid biopsy)

Recruiting
  • Non Small Cell Lung Cancer
  • Advanced Solid Tumor
  • EGFR gene mutation analysis on liquid biopsy
  • Angers, France
  • +8 more
Feb 2, 2022

Colorectal Cancer, Resectable Colorectal Carcinoma Trial in Milan (Trastuzumab deruxtecan, Durvalumab, Panitumumab)

Active, not recruiting
  • Colorectal Cancer
  • Resectable Colorectal Carcinoma
  • Trastuzumab deruxtecan
  • +4 more
  • Milan, Lombardia/MI, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
Apr 26, 2023

Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in United

Recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • +2 more
  • Birmingham, Alabama
  • +10 more
Jan 25, 2023

Advanced NSCLC Trial in China (Gene Profile explore)

Recruiting
  • Advanced NSCLC
  • Gene Profile explore
  • Beijing, China
  • +14 more
Jan 27, 2023

Solid Tumor, Adult Trial in Richmond (Neratinib, Divalproex Sodium)

Recruiting
  • Solid Tumor, Adult
  • Richmond, Virginia
    Virginia Commonwealth University Massey Cancer Center
Mar 2, 2022

Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Columbus

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Jul 14, 2022

Lung Cancer Trial in Worldwide (Erlotinib, Bevacizumab)

Completed
Has Results
  • Lung Cancer
  • Caen, France
  • +47 more
Aug 23, 2022

Diabetic Nephropathy Type 2 Trial in Milano (Comparison of eGFR values and ketonemia in diabetic patients)

Active, not recruiting
  • Diabetic Nephropathy Type 2
  • Comparison of eGFR values and ketonemia in diabetic patients
  • Milano, Italy
    ASST FBF-Sacco P.O. Sacco/Fatebenefratelli e Oftalmico
Sep 27, 2021

Thickening of Bowman's Capsule on Clinical Prognosis of Diabetic

Not yet recruiting
  • Diabetic Kidney Disease
  • Extracellular Matrix Alteration
  • no intervention
  • (no location specified)
Sep 15, 2023

Metastatic Lung Cancer Trial in France (InvisionFirst® molecular panel)

Active, not recruiting
  • Metastatic Lung Cancer
  • InvisionFirst® molecular panel
  • Bayeux, France
  • +15 more
Aug 22, 2022

NSCLC Trial in Guangzhou (Avitinib Maleate, Afatinib, Crizotinib)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Avitinib Maleate
  • +13 more
  • Guangzhou, Guangdong, China
    Guangdong Lung Cancer Institute, Guangdong Provincial People's H
Dec 3, 2022

Soft Tissue Sarcoma Trial in France (drug, combination product, other)

Recruiting
  • Soft Tissue Sarcoma
  • Bordeaux, France
  • +17 more
Oct 4, 2022

Plasma Genotyping asNoninvasive Biomarker for Genotype-directed

Recruiting
  • NSCLC
  • Melanoma
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Mar 1, 2022

    Immunotherapy + Chemotherapy in Non-Small Cell Lung Cancer

    Recruiting
    • Non-small Cell Lung Cancer
      • Lille, France
      • +3 more
      Jan 25, 2023

      Glioblastoma Multiforme Trial in United States (ERAS-801)

      Recruiting
      • Glioblastoma Multiforme
      • Los Angeles, California
      • +6 more
      Nov 14, 2022

      Multi-omics Analysis of Chronic Kidney Disease

      Recruiting
      • Potential Mechanisms Underlying the Microbiota-Gut-Kidney Axis in CKD
      • renal function
      • Shanghai, Shanghai, China
        Department of Nephrolgoy, Shanghai 10th People's Hospital
      Sep 13, 2022

      Brain Tumor Trial in Houston (tepotinib, tepotinib plus osimertinib)

      Not yet recruiting
      • Brain Tumor
      • Houston, Texas
        M D Anderson Cancer Center
      Jul 18, 2022

      Non-small-cell Lung Carcinoma Trial in Netherlands (biopsy, ctDAN analysis)

      Recruiting
      • Non-small-cell Lung Carcinoma
      • biopsy
      • ctDAN analysis
      • Amsterdam, Noord-Holland, Netherlands
      • +5 more
      Feb 2, 2021

      Genomic Alteration in Luminal A or Luminal B Subtypes

      Active, not recruiting
      • Breast Cancer
        • Athens, Greece
          George Fountzilas
        Mar 15, 2022

        Hypertension Secondary to Kidney Transplant Trial in New Hyde Park, Philadelphia (New Medication: Enalapril, Isradipine,

        Completed
        Has Results
        • Hypertension Secondary to Kidney Transplant
        • New Medication: Enalapril, Isradipine, Propranolol
        • New Hyde Park, New York
        • +1 more
        Apr 11, 2021

        NSCLC Trial (Furmonertinib)

        Not yet recruiting
        • Non-Small Cell Lung Cancer
        • (no location specified)
        Aug 10, 2023

        NSCLC (NSCLC) Trial (MK-2870, Docetaxel, Pemetrexed)

        Not yet recruiting
        • Non-small Cell Lung Cancer (NSCLC)
        • MK-2870
        • +2 more
        • (no location specified)
        Oct 3, 2023